Spinal Surgery Devices Market: Global Market Analysis, Dynamics, Country Share, Trends, Competitor Analysis 2013 – 2017 and Forecast 2018 – 2025

Global Spinal Surgical Devices market is set to surpass US$ 12.5 Billion by 2025.
Market growth can be attributed to factors such as increasing preference for Minimally Invasive Spinal Surgery (MISS) procedures, increasing geriatric and obese population with increasing number of spine deformities and technological advancements in spine surgery devices are the key factors fuelling the growth of the spinal surgical devices market.
Spinal Surgical Devices Market: Country–wise Outlook
United States is expected to lead the spinal surgical devices market with a total market share of over 50% by 2025. Japan has shown its potential to become leading #2 market with more than XX% market share in 2017 and is expected to maintain its #2 position during the forecast period. China is expected to become the third largest spinal surgical devices market by 2025.
Spinal Surgical Devices Market: Key Players Outlook
DePuy Synthes dominates the global spinal surgical devices market. Medtronic captured second highest share of the global spinal surgical devices market in 2017 and is expected to maintain its position till the forecast period. Nuvasive and Zimmer Bionet is competing closely with each other to grab maximum share of the global spinal surgical devices market.
The report titled “Spinal Surgery Devices Market: Global Market Analysis, Dynamics, Country Share, Trends, Competitor Analysis 2013 – 2017 and Forecast 2018 – 2025”examines the market, demand, competitive landscape and trends of the ten major markets of the spinal surgical devices market. It provides essential insights into spinal surgical devices market for the top 10 countries, comprising the US, the UK, France, Italy, Spain, Germany, Japan, China, India and Brazil until 2025. Key trends in terms of collaborations, partnerships, licensing and development agreements, merger and acquisition and distribution agreement are analysed with details. The report also explores detailed description of growth drivers and inhibitors of the spinal surgery devices market.
The report concludes with the profiles of major players in the spinal surgery devices market. The major market players are evaluated on various parameters such as company overview, market revenue and latest development and trends of the spinal surgery devices market.
The Major Companies Dominating this Market for its Products, Services and Continuous Product Developments are:
Medtronic, Zimmer Bionet, Stryker, DePuy Synthes, NuVasive, Globus Medical, Orthofix International, K2M Medical, SeaSpine, Alphatec Holdings
Ten Major Markets(10MM) Covered in the Report are as follows:
United States, United Kingdom, France, Italy, Spain, Germany, Japan, China, India, Brazil
The Latest Industry Data Included in this Report:
• Global Spinal Surgical Devices Market & Forecast (2013 – 2025)
• Global Spinal Surgical Devices Market Share & Y-o-Y Growth (%)
• Global Spinal Surgical Devices Market Share, by Major Companies, 2013 – 2025
• Global Spinal Surgical Devices Market Share by Major Countries, 2013 – 2025
• Global Spinal Surgical Devices Market, By Geography, 2013 – 2025
• Major Deals in Spinal Surgical Devices Market
• Major Companies Market Revenue & Forecast (2013 – 2025)
• Major Companies Latest Development & Trends
• Market Definition for the Specified Topic Along with Identification of Key Drivers
   and Inhibitors for the Market
Advertisements

Global Insulin Delivery Pen Market 2018

Insulin Delivery Pen Market is expected to exceed US$ 14 Billion across the ten major markets (10MM) by 2025.
The report “Global Insulin Delivery Pen Market Analysis, Size, Share, Segmentation and Competitive Landscape (2012 – 2017) and Future Forecast (2018 – 2025)” offers the most up-to-date industry data on the actual market situation and future outlook for insulin pen across the ten major markets (10MM). The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, volume, revenues for insulin pen and its segments reusable and disposable insulin pen and illustrative forecast to 2025. A comprehensive analysis has been done on market share of insulin pen segment.
The Major Companies Dominating this Market for its Products, Services and Continuous Product Developments are:
Novo Nordisk, Eli Lilly, Sanofi, Owen Mumford, Ypsomed, Biocon Ltd.
Key Findings:
• Germany accounted for 15% of the insulin delivery pen market in 2017
• China dominates the reusable insulin delivery pen market
• Reusable insulin delivery pen has the highest volume share in the overall insulin delivery pen market
• Disposable insulin delivery pen is expected to register a faster value growth during 2018-2025
• Japan is the third largest insulin delivery pen market
• Flexpen, Solostar and KwikPen are the leading brand in the insulin delivery pen sector
The Latest Industry Data Included in this Report:
• Diabetes Population in 10 major market(10MM) 2011-2025
• Insulin Users Insights in 10 major market(10MM) 2011-2025
• Overall Insulin Delivery Pen Users, 2011-2025
• Overall Insulin Delivery Pen Market Size, 2011-2025
• Insulin Delivery Pen Market Size by Product Segments, 2011-2025
• Growth Rates of the Overall Market and Different Product Segments, 2011-2025
• Shares of Different Product Segments of the Overall Market, 2011- 2025
• Market Definition for the Specified Topic Along with Identification of Key Drivers
   and Inhibitors for the Market
• A Comprehensive List of Key Market Players Along with the Analysis of their Current
  Product Portfolios and Recent Development
The Report Facilitates Answer the Subsequent Questions:
• What is the size of the insulin delivery pen market in 10 major market(10MM)?
• How much reusable and disposable pen users in 10 major market(10MM)?
• How is the insulin delivery pen market divided into two different types of segments?
• How are the overall market and segments types growing?
• How is the market predicted to develop in the future?
• Who are the market players?

Singapore’s Tourism Board And NATAS To Partner With The FinLab To Help Travel Agencies Evolve Through Digital Transformation

Source: https://www.opengovasia.com/articles/singapores-tourism-board-and-natas-to-partner-with-the-finlab-to-help-travel-agencies-evolve-through-digital-transformation

The Ministry of Communications and Information announced that The FinLab would be collaborating with the Singapore Tourism Board (STB) and the National Association of Travel Agents Singapore (NATAS) to help travel agencies evolve and renovate their businesses via a digital transformation programme for the selected businesses.

Singapore’s economy relies heavily on the tourism industry, which accounts for approximately four per cent of its annual gross domestic product. However, changing consumer behaviour and the growing competition for tourism dollars regionally pose a significant challenge to the industry.

Consequently, to ensure the industry’s continued growth, it is important for members of the industry to grasp the currently available opportunities in the online travel market, particularly those in the Asia Pacific online travel market, which is expected to grow by 13 per cent by focusing on technological transformation.

None the less, it was noted that despite most consumers moving to online booking sites, travel agencies retain the opportunity to go beyond the usual issuance of e-tickets and vouchers and, in addition to these services, provide consumers with more personalised services. Thus, travel agencies must understand how they can apply digital solutions to understand and connect more effectively with their target audience along with personal interaction.

In the face of a dynamic economic landscape in Singapore, travel agencies and the companies and initiatives that seek to help them grow and transform must remain constantly cognizant of the challenges that SMEs (small and medium-sized enterprises) face in harnessing the potential of technology and in transforming it into benefits for their businesses.

Experts maintain that in order for the travel industry to continue to capitalise on growth opportunities in the long-term it must continue to innovate. One avenue to do this is to collaborate with partners who have the expertise to assist Singapore’s travel agents in developing digital competencies.

The FinLab, a partnership between SGInnovate and United Overseas Bank (UOB), is a business accelerator formed to propel technology companies and catalyse the digital transformation of businesses.

The FinLab’s programme presents the selected Singaporean travel agencies the opportunity to not only connect to The Finlab’s ecosystem of associates to transform their business digitally but also enables them to use what they have learned to improve their business’ performance, enhance consumer experiences and seize business opportunities present in the digital economy.

Ms Ong Ling Lee, Director at Travel Agents and Tourist Guides, STB stated that their collaboration with The FinLab is one of several initiatives created to support travel agencies and help them grown and transform their businesses in an increasingly competitive tourism market. “We hope that with the practical guidance provided by this acceleration programme, travel agents will be encouraged to take the first step towards achieving their growth ambitions”, Ms Lee added.

Advanced Oncotherapy (AVO) Selects RayStation for the First LIGHT System in Central London

Source: https://www.prnewswire.com/news-releases/advanced-oncotherapy-avo-selects-raystation-for-the-first-light-system-in-central-london-300676566.html

The UK based developer of next generation proton therapy technology, Advanced Oncotherapy plc (AVO), has selected RayStation as its treatment planning system for the first LIGHT (Linac Image Guided Hadron Technology) system at the proton therapy facility under construction at Harley Street in central London. Users at the clinic will have access to the full spectrum of RayStation’s functionality.

AVO and RaySearch have entered into a collaboration agreement to support the LIGHT system fully. The LIGHT system is a modular proton therapy system based on innovative technology, developed in a collaboration between the TERA project and CERN in Geneva, Switzerland. The heart of the system consists of a treatment room integrated with a linear accelerator, which accelerates protons to energies suitable for radiation therapy of cancer. The entire system is designed for cost effectiveness and low maintenance and has several key features, such as multiple spot sizes and fast energy switching time.

The order of RayStation for Harley street gives the users access to the full spectrum of RayStation’s functionality, including the fast proton Monte Carlo dose engine, robust 4D optimization, LET driven optimization, deformable registration, dose accumulation, plan adaptation, multi-criteria optimization and Plan Explorer for automatic plan generation.

Nicolas Serandour, AVO Chief Executive Officer, says: “We are thrilled to collaborate with RaySearch. RaySearch has established themselves as the technology of choice for light ion therapy treatment planning. As we bring our advanced particle therapy treatment technology into the field, it makes sense to have the most advanced treatment planning capability to complement it. We believe the synergetic combination is significant for optimizing patient care at our first proton therapy center in the renowned medical practice area of Harley Street, London.”